Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00153452 · ClinicalTrials.gov registry record
Workplace Productivity of Persons Who Use Controlling Behavior With Intimate Partners
A clinical trial, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- 630
- Enrollment target
NCT00153452: Completed study, sponsored by Centers for Disease Control and Prevention.
NCT00153452 is a clinical trial that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 630 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00153452 has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- 630 participants
- Enrollment target
Study Summary
The goal of this project is to pilot-test an instrument that is designed to assess the relationship between persons who use controlling behavior with intimate partners, as a risk factor for perpetrating intimate partner violence, and workplace productivity. The goal is to validate a survey instrument that can be applied to other workplace settings to measure productivity losses associated with controlling and aggressive behavior, which will serve to inform the development of workplace interventions designed to prevent intimate partner violence (IPV). This pilot-test will include two components of a survey conducted with employees in a workplace setting: questions to determine one's controlling behavior or propensity for violence in an intimate relationship, and questions designed to assess levels of productivity as measured by days missed from work (absenteeism) and days at work with diminished functional output (presenteeism). We expect productivity to decrease as one's controlling behavior or propensity for perpetrating IPV increases. This study represents one of the first workplace surveys designed to measure workplace productivity as a function of controlling or violent behavior. Successful results would argue for a more wide-scale testing of the instrument, which could ultimately lead to the development of workplace interventions designed to prevent IPV.
Interventions
- BEHAVIORAL perpetration of intimate partner violence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 630 participants |
| Start Date | 2004-11 |
| Est. Completion | 2005-07 |
What the finished NCT00153452 record still lists
NCT00153452 is an observational study that tracks outcomes without assigning an intervention. The registered 630 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which perpetration of intimate partner violence is the first listed.
NCT00153452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00153452 about?
NCT00153452 is a clinical study titled "Workplace Productivity of Persons Who Use Controlling Behavior With Intimate Partners". The goal of this project is to pilot-test an instrument that is designed to assess the relationship between persons who use controlling behavior with intimate partners, as a risk factor for perpetrating intimate partner violence, and workplace productivity. The goal is to validate a survey instrumen...
What is the current status of trial NCT00153452?
This trial is currently completed. The enrollment target is 630 participants. The study started on 2004-11. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00153452?
The interventions under investigation include: perpetration of intimate partner violence (BEHAVIORAL).
Who is sponsoring clinical trial NCT00153452?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia